Skip to main content
Fig. 1 | BMC Women's Health

Fig. 1

From: Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy

Fig. 1

Stratified analyses of recurrence-free survival (RFS) based on risk factors. (A) Survival analyses of patients based on the FIGO stage (I, II, and III C: 92.5%, 85.1%, and 71.9%, respectively). (B) Five-year RFS rates of patients based on tumor diameter (> 4 cm vs. ≤4 cm; 65.8% vs. 88.2%, respectively). (C) Five-year RFS rates of patients with ESCC stratified by parametrial invasion (pos. vs. neg.; 32.1% vs. 83.3%, respectively). (D) Five-year RFS stratified by number of positive lymph nodes (0, 1–2, vs. ≥3, 88.6%, 75.6%, vs. 47.7%, respectively)

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us